ACHC — Acadia Healthcare Share Price
Last trade - 00:00- $6.76bn
- $8.15bn
- $2.93bn
- 73
- 33
- 69
- 60
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 19.9 | ||
| PEG Ratio (f) | 1.35 | ||
| EPS Growth (f) | 17.25% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.43 | ||
| Price to Tang. Book | 14.01 | ||
| Price to Free Cashflow | 177.03 | ||
| Price to Sales | 2.31 | ||
| EV to EBITDA | 45.46 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.05% | ||
| Return on Equity | -0.77% | ||
| Operating Margin | 1.61% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 2,008.38 | 2,089.93 | 2,314.39 | 2,610.4 | 2,928.74 | 3,220.33 | 3,539.51 | 8.99% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -17.93 | +86.6 | +44.13 | +15.33 | -0.86 | +18.79 | +14 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Acadia Healthcare Company, Inc. provides behavioral healthcare services across the United States. Its facilities and services are classified into various categories: acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs) and residential treatment centers. Outpatient programs associated with its facilities are included within each respective service line. Its acute inpatient psychiatric facilities provide a high level of care in order to stabilize patients that are either a threat to themselves or to others. Its specialty treatment facilities include residential recovery facilities and eating disorder facilities. It operates over 10 CTC locations in North Carolina and 160 locations in 32 states across the country. Its residential treatment centers treat patients with behavioral disorders in a non-hospital setting. It operates a network of over 253 behavioral healthcare facilities with 11,200 beds in 38 states and Puerto Rico.
Directors
- Reeve Waud NEC (57)
- David Duckworth CFO (41)
- Larry Harrod EVF (64)
- Christopher Howard EVP (54)
- John Hollinsworth EVP (57)
- Debra Osteen DRC (65)
- Jason Bernhard IND (55)
- E. Perot Bissell IND (61)
- Michael Fucci IND (62)
- Vicky Gregg IND (66)
- William Grieco IND (67)
- Wade Miquelon IND (56)
- William Petrie IND (74)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- October 24th, 2005
- Public Since
- November 1st, 2011
- No. of Shareholders
- 598
- No. of Employees
- 17,000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 92,427,916
- Address
- SUITE 610, 830 CRESCENT CENTRE DRIVE, FRANKLIN, 37067
- Web
- https://www.acadiahealthcare.com/
- Phone
- +1 6158616000
- Auditors
- Ernst & Young LLP
Latest News for ACHC
Upcoming Events for ACHC
Q1 2024 Acadia Healthcare Company Inc Earnings Release
Q1 2024 Acadia Healthcare Company Inc Earnings Call
Acadia Healthcare Company Inc Annual Shareholders Meeting
Acadia Healthcare Company Inc Annual Shareholders Meeting
Q2 2024 Acadia Healthcare Company Inc Earnings Release
Similar to ACHC
23andMe Holding Co.
NASDAQ Global Select Market
Accolade
NASDAQ Global Select Market
Addus HomeCare
NASDAQ Global Select Market
Alignment Healthcare
NASDAQ Global Select Market
Amedisys
NASDAQ Global Select Market
FAQ
As of Today at 19:00 UTC, shares in Acadia Healthcare are trading at $73.18. This share price information is delayed by 15 minutes.
Shares in Acadia Healthcare last closed at $73.18 and the price had moved by -2.93% over the past 365 days. In terms of relative price strength the Acadia Healthcare share price has underperformed the S&P500 Index by -21.61% over the past year.
The overall consensus recommendation for Acadia Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Acadia Healthcare does not currently pay a dividend.
Acadia Healthcare does not currently pay a dividend.
Acadia Healthcare does not currently pay a dividend.
To buy shares in Acadia Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $73.18, shares in Acadia Healthcare had a market capitalisation of $6.76bn.
Here are the trading details for Acadia Healthcare:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: ACHC
Based on an overall assessment of its quality, value and momentum Acadia Healthcare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Acadia Healthcare is $95.58. That is 30.61% above the last closing price of $73.18.
Analysts covering Acadia Healthcare currently have a consensus Earnings Per Share (EPS) forecast of $3.54 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Acadia Healthcare. Over the past six months, its share price has underperformed the S&P500 Index by -18.16%.
As of the last closing price of $73.18, shares in Acadia Healthcare were trading -4.66% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Acadia Healthcare PE ratio based on its reported earnings over the past 12 months is 19.9. The shares last closed at $73.18.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Acadia Healthcare's management team is headed by:
- Reeve Waud - NEC
- David Duckworth - CFO
- Larry Harrod - EVF
- Christopher Howard - EVP
- John Hollinsworth - EVP
- Debra Osteen - DRC
- Jason Bernhard - IND
- E. Perot Bissell - IND
- Michael Fucci - IND
- Vicky Gregg - IND
- William Grieco - IND
- Wade Miquelon - IND
- William Petrie - IND